Eotaxin-2/CCL24, human recombinant protein
C-C motif chemokine 24, Small-inducible cytokine A24, Myeloid progenitor inhibitory factor 2, CK-β-6
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | O00175 |
---|---|
Calculated MW | 8.8 kDa |
Gene ID | 6369 |
---|---|
Gene Symbol | CCL24 |
Other Names | C-C motif chemokine 24, Small-inducible cytokine A24, Myeloid progenitor inhibitory factor 2, CK-β-6, Eosinophil chemotactic protein 2, Eotaxin-2, CCL24, Ckb-6, MPIF2, MPIF-2, SCYA24, Eotaxin2, CCL-24. |
Gene Source | Human |
Source | E. coli |
Assay&Purity | SDS-PAGE; ≥97% |
Assay2&Purity2 | HPLC; |
Recombinant | Yes |
Results | 50-100 ng/ml |
Target/Specificity | Eotaxin-2/CCL24 |
Application Notes | Reconstitute in H₂O to a concentration of 0.1-1.0 mg/ml. This solution can be stored at 4°C for 1 week or –20°C for future use. It is recommended that further dilutions be made into buffer containing carrier protein or medium containing serum. |
Format | Lyophilized protein |
Storage | -20°C; The protein was lyophilized from a concentrated (1 mg/ml) sterile solution containing 20 mM PBS pH-7.4 and 0.15 M sodium chloride. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Eotaxin-2 also known as MPIF-2 is a CC chemokine characterized by its high chemotactic selectivity for eosinophils. BioVision’s human eotaxin-2 is 8.8 kDa protein containing 78 amino acid residues.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.